ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352330 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352330; 2) Community: the network communities that were significantly associated with the response to NSC 352330; 3) Molecule: the relationships between components within communities and NSC 352330; 4) MDR: the compounds that were significantly associated with the NSC 352330.

NSC Compound Enrichment Correlation
NSC 634368 Chlorobis(4-ethyltropolonato)bismuth(III) 0.0115521552688257 0.52457009
NSC 640084 Null 0.0115521552688257 0.34121396
NSC 648365 Insulin-Methotrexate conjugate 0.0115521552688257 0.33321068
NSC 662253 Null 0.0115521552688257 0.57451894
NSC 666571 7.alpha.-Methyl-3,11.beta.,17.beta.-trihydroxy estra-1,3,5(10)triene 11-nitrate ester 0.0115521552688257 0.32337178
NSC 671165 Null 0.0115521552688257 0.29298433
NSC 671865 Null 0.0115521552688257 0.25220841
NSC 676916 1-[m-methyl anilino malonyl]-3-methyl-4-[4'-.beta.-sulphato ethyl sulphonyl phenyl azo]-5-pyrazolone 0.0115521552688257 0.3630839
NSC 682827 Propanimidoyl chloride, 2-methyl- N-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]oxy]- 0.0115521552688257 0.67874021
NSC 682831 Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- 0.0115521552688257 0.70980456
Total:139  Current:57    [First] [Prev] [Next] [Last]